Investors Sue BioVie (BIVI) After Potential Scientific Misconduct In Failed Phase 3 Clinical Trial Uncovered- Hagens Berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages BIVI Investors with Substantial Losses to Contact its AttorneysSan Francisco, California--(New...

Related Keywords

San Francisco ,California ,United States ,Reed Kathrein ,Hagens Berman ,Office Of Scientific Integrity ,California Newsfile Corp ,Nasdaq ,Biovie Inc ,Substantial Losses ,Plaintiff Deadline ,Securities Class Action ,Good Clinical Practice ,Scientific Integrity ,